Dr. Halsey's presentation at the National Vaccine Advisory Committee Workshop on Thimerosal and Vaccines held in Bethesda, Maryland on August 11-12, 1999.

Slide Notes:

We need to tell physicians and parents about the options available for reducing mercury exposures. If only a single thimerosal-containing vaccine is administered such as Hib or DTaP at two, four and six months of age, then only the very smallest infants receive more than the total monthly mercury exposure allowed under the ATSDR guidelines.